Creation of Novel Cell-Penetrating Peptides for Intracellular Drug Delivery Using Systematic Phage Display Technology Originated from Tat Transduction Domain
-
- Kamada Haruhiko
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
- Okamoto Takayuki
- Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University Department of Molecular Pathobiology, Mie University School of Medicine
-
- Kawamura Maki
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Shibata Hiroko
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Abe Yasuhiro
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Ohkawa Akiko
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Nomura Tetsuya
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Sato Masaki
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Mukai Yohei
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Sugita Toshiki
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Imai Sunao
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Nagano Kazuya
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Tsutsumi Yasuo
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Nakagawa Shinsaku
- Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
- Mayumi Tadanori
- Department of Cell Therapeutics, Graduate School of Pharmaceutical Sciences, Kobe Gakuin University
-
- Tsunoda Shin-ichi
- Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
この論文をさがす
抄録
Many biologically active proteins need to be delivered intracellularly to exert their therapeutic action inside the cytoplasm. Cell penetrating peptides (CPPs) have been developed to efficiently deliver a wide variety of cargo in a fully biological active form into a range of cell types for the treatment of multiple preclinical disease models. To further develop this methodology, we established a systematic approach to identify novel CPPs using phage display technology. Firstly, we screened a phage peptide library for peptides that bound to the cell membrane. Secondly, to assess functionality as intracellular carriers, we recombined cDNAs of binding peptides with protein synthesis inhibitory factor (PSIF) to create fusion proteins. Randomly chosen clones were cultured and expression of peptide-PSIF fusion proteins induced, followed by screening of protein synthesis activity in cells. Using this systematic approach, novel and effective CPPs were rapidly identified. We suggest that these novel cell-penetrating peptides can utilized as drug delivery tools for protein therapy or an analytical tool to study mechanisms of protein transduction into the cytoplasm.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 30 (2), 218-223, 2007
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679602600064
-
- NII論文ID
- 110006162832
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 8616012
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可